News

Merck and BigHat BioSciences Partner on Drug Discovery Programs

December 01, 2022

Merck will use BigHat’s AI/machine learning-enabled platform to design candidates for up to three drug discovery programs.

AstraZeneca Acquires Neogene Therapeutics for $320 Million

November 30, 2022

AstraZeneca inked a deal worth up to $320 million to purchase Neogene Therapeutics, a biotech start-up focused on T-cell receptor therapies.

Pfizer, Merck KGaA, and Immutep Enter into Second Clinical Trial Collaboration Agreement

November 30, 2022

The agreement will see Immutep and Merck KGaA, Darmstadt, Germany jointly fund the INSIGHT-005 study.

Aptamer Group Opens New Facility in United Kingdom

November 30, 2022

Aptamer’s new 18,000 ft² facility will expand the company's capacity to deliver novel binders for bioprocessing, diagnostic, and drug development.

Etihad Cargo Achieves IATA CEIV Pharma Recertification for Pharmaceutical Logistics

November 30, 2022

Etihad Cargo is one of the only airlines to hold IATA CEIV Pharma certification globally.

Phase III Study for Novel Ganaplacide/Lumefantrine-SDF Combination in Adults, Children with Malaria Announced

November 29, 2022

The decision to move forward in Phase III development stems from the threat of resistance to current malaria treatment growth.

Next Step in Clinical Development of Respiratory Drug Candidate SPX-001 Confirmed

November 28, 2022

SPX-001, a respiratory drug candidate, will be submitted through a combined Clinical Trial and Ethics Committee application for further advancement in the clinical stages.

FDA Approves $3.5 Million Hemophilia B Gene Therapy

November 28, 2022

CSL’s Hemgenix (etranacogene dezaparvovec) will cost approximately $3.5 million, making it the most expensive single-use medicine in the United States.

Merck Announces $1.35 Billion Acquisition of Imago BioSciences

November 28, 2022

Merck will purchase Imago BioSciences, a biotechnology company focused on bone marrow disorders, for approximately $1.35 billion.

Sartorius BIA Separations and Exopharm Sign Joint Research Agreement

November 28, 2022

The agreement aims to develop integrated technology for large-scale exosome production.